Abstract
AIM: To assess the clinical efficacy of micro-ecological agents in the treatment of mild and moderate ulcerative colitis.
METHODS: Ninety-six patients with mild and moderate ulcerative colitis who were treated at Department of Gastroenterology of Fengtai Hospital Affiliated to Capital Medical University from January 2012 to December 2015 were selected, and they were randomly divided into either an observation group or a control group according to the order of admission. Patients in the control group received treatment with mesalazine, while patients in the observation group were treated with mesalazine combined with micro-ecological agents Bifico. All patients were treated for 12 wk. Ulcerative colitis activity index (UCAI) score, serum level of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and clinical efficacy were compared between the two groups after treatment.
RESULTS: Patients' age, gender, severity of disease, UCAI score, serum level of CRP, and ESR did not differ significantly between the two groups before treatment (P > 0.05). After treatment, UCAI score, serum level of CRP, and ESR were significantly lower than those before treatment in both groups (P < 0.05), and the decrease was more significant in the observation group than in the control group (P < 0.05). The total effective rate of the observation group was 95.8%, which was significantly higher than 79.2% of the control group (χ2 = 4.667, P = 0.031).
CONCLUSION: In the treatment of mild and moderate ulcerative colitis, mesalazine combined with micro-ecological agents can not only correct intestinal microflora disorders and maintain the intestinal micro-environment, but also reduce serum levels of inflammatory cytokines.
Collapse